BACKGROUND: Through the AMI-QUEBEC Study we sought to describe delays to reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) and to identify factors associated with prolonged delays. METHODS: We reviewed the charts of all consecutive patients with STEMI admitted to 17 hospitals in the province of Quebec in 2003 to obtain data on the time from presentation to reperfusion therapy. Data were available for 1189 (83.0%) of 1432 patients. RESULTS: The median delay to reperfusion therapy was 32 minutes (first and third quartile [Q1, Q3] 20, 49) for 535 patients who received fibrinolytic therapy, 109 minutes (Q1, Q3 79, 150) for 455 patients who underwent primary percutaneous coronary intervention (PCI) at the initial hospital of presentation and 142 minutes (Q1, Q3 115, 194) for 199 patients who underwent primary PCI after an interhospital transfer. Patients who presented outside daytime working hours, those who received primary PCI and those who required interhospital transfer for primary PCI were less likely to receive reperfusion therapy within current recommended times (odds ratios [ORs] 0.49, 0.56 and 0.15, respectively). Increased age was associated with prolonged delays only among patients who received fibrinolytic therapy (OR for each 10-year increase in age 0.95, 95% credible interval [CrI] 0.93-0.99 for fibrinolytic therapy and 0.99, 95% CrI 0.95-1.05, for primary PCI). INTERPRETATION: In 2003, many patients with STEMI in Quebec were not treated within the recommended times. Delays may be reduced by reorganizing pre-and in-hospital care for patients with STEMI to expedite delivery of reperfusion therapy.
BACKGROUND: Through the AMI-QUEBEC Study we sought to describe delays to reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) and to identify factors associated with prolonged delays. METHODS: We reviewed the charts of all consecutive patients with STEMI admitted to 17 hospitals in the province of Quebec in 2003 to obtain data on the time from presentation to reperfusion therapy. Data were available for 1189 (83.0%) of 1432 patients. RESULTS: The median delay to reperfusion therapy was 32 minutes (first and third quartile [Q1, Q3] 20, 49) for 535 patients who received fibrinolytic therapy, 109 minutes (Q1, Q3 79, 150) for 455 patients who underwent primary percutaneous coronary intervention (PCI) at the initial hospital of presentation and 142 minutes (Q1, Q3 115, 194) for 199 patients who underwent primary PCI after an interhospital transfer. Patients who presented outside daytime working hours, those who received primary PCI and those who required interhospital transfer for primary PCI were less likely to receive reperfusion therapy within current recommended times (odds ratios [ORs] 0.49, 0.56 and 0.15, respectively). Increased age was associated with prolonged delays only among patients who received fibrinolytic therapy (OR for each 10-year increase in age 0.95, 95% credible interval [CrI] 0.93-0.99 for fibrinolytic therapy and 0.99, 95% CrI 0.95-1.05, for primary PCI). INTERPRETATION: In 2003, many patients with STEMI in Quebec were not treated within the recommended times. Delays may be reduced by reorganizing pre-and in-hospital care for patients with STEMI to expedite delivery of reperfusion therapy.
Authors: Eric A Shry; Robert E Eckart; Joshua B Winslow; William A Rollefson; Daniel E Simpson Journal: Am J Cardiol Date: 2003-04-01 Impact factor: 2.778
Authors: Bruce R Brodie; Thomas D Stuckey; Denise B Muncy; Charles J Hansen; Thomas C Wall; Mark Pulsipher; Navin Gupta Journal: Am Heart J Date: 2003-04 Impact factor: 4.749
Authors: P B Berger; S G Ellis; D R Holmes; C B Granger; D A Criger; A Betriu; E J Topol; R M Califf Journal: Circulation Date: 1999-07-06 Impact factor: 29.690
Authors: Elizabeth H Bradley; Sarah A Roumanis; Martha J Radford; Tashonna R Webster; Robert L McNamara; Jennifer A Mattera; Barbara A Barton; David N Berg; Edward L Portnay; Harry Moscovitz; Janet Parkosewich; Eric S Holmboe; Martha Blaney; Harlan M Krumholz Journal: J Am Coll Cardiol Date: 2005-10-04 Impact factor: 24.094
Authors: Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs Journal: Circulation Date: 2004-08-31 Impact factor: 29.690
Authors: Richard E Waters; Kanwar P Singh; Matthew T Roe; Mat Lotfi; Michael H Sketch; Kenneth W Mahaffey; L Kristin Newby; John H Alexander; Robert A Harrington; Robert M Califf; Christopher B Granger Journal: J Am Coll Cardiol Date: 2004-06-16 Impact factor: 24.094
Authors: Thao Huynh; Jafna L Cox; David Massel; Cheryl Davies; Joseph Hilbe; Wayne Warnica; Paul A Daly Journal: Am Heart J Date: 2004-07 Impact factor: 4.749
Authors: Rober C Welsh; Luc Sauriol; Zugui Zhang; Paul Kolm; Willian S Weintraub; Pierre Theroux Journal: Can J Cardiol Date: 2009-12 Impact factor: 5.223
Authors: Patrick Garceau; Jean-Pierre Déry; Philippe Lachance; Stéfanie Grenier; Josep Rodés-Cabau; Gérald Barbeau; Olivier F Bertrand; Onil Gleeton; Eric Larose; Can Man Nguyen; Bernard Noël; Guy Proulx; Louis Roy; Robert de Larochellière Journal: Can J Cardiol Date: 2007-10 Impact factor: 5.223
Authors: Kendeep S Kaila; Kapil M Bhagirath; Malek Kass; Lorraine Avery; Lillian Hall; Alex H Chochinov; James W Tam Journal: Mcgill J Med Date: 2007-07
Authors: Kevin A Brown; Laurie J Lambert; James M Brophy; James Nasmith; Stéphane Rinfret; Eli Segal; Simon Kouz; Dave Ross; Richard Harvey; Sébastien Maire; Lucy J Boothroyd; Peter Bogaty Journal: PLoS One Date: 2014-08-21 Impact factor: 3.240